Michal Silverberg
Angel · California
Board director at 5 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Apr 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: ONL TherapeuticsMar 15, 2023
- SEC Form D: Redona TherapeuticsJul 31, 2023
- SEC Form D: Capstan TherapeuticsMar 20, 2024
- SEC Form D: ImmPACT Bio USAApr 2, 2024
- SEC Form D: Averna TherapeuticsApr 17, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.